Yasmin Blood Clots – Same as Yaz

Yaz and Yasmin are both drospirenone-based oral contraceptives that are manufactured by Bayer Pharmaceuticals, a pharmaceuticals giant that is one of the largest in the nation. Many patients wonder what the difference is between the two medications, or whether the extremely publicized Yaz side effects associated with the birth control are also linked to Yasmin. Consumers want to be able to make an educated decision when it comes to their medical treatments and the drugs they take, and it is natural for patients to wonder whether they are safe.

Yaz Side Effects Are Even More Terrifying Due To Young Deaths

As of February 2011, Bayer faced nearly 7,000 Yaz lawsuits against their birth control pills and the number of new claims is continuing to grow. It is anticipated that to resolve the litigation, the pharmaceutical company will ultimately need to reach Yaz settlements and Yasmin settlements with up to 25,000 women. The injury lawsuits for Yaz and Yasmin involve claims that Bayer failed to adequately research their popular birth control pills and warn about the increased risk of serious and potentially life threatening side effects of Yasmin and Yaz. Settlement compensation is being pursued by women who have suffered injuries such as: heart attack or stroke, pulmonary embolism from, deep vein thrombosis and gallbladder problems. Bayer is currently indicating that they intend to fight the cases and do not have any plans to settle Yaz or Yasmin lawsuits.

Yaz Side Effects Now Include Pancreatitis, According to FDA

The Food and Drug Administration has issued an order to all manufacturers of certain birth control pills to include pancreatitis on warning labels of birth control pills that contain the hormones drospirenone and estrogen. Such oral contraceptives, including the controversial Yaz and Yasmin brands, have been linked to pancreatitis in the past, but it is now clear that there is a definitive link as the disease is now an “official” side effect. The Food and Drug Administration’s order could cause legal trouble for many drugmakers. Individuals are contacting Yaz lawyers to discuss how to pursue legal action.

Yaz Lawyers Inform Clients of Differences in Side Effects

Many patients who have experienced Yaz side effects, including deep vein thrombosis and pulmonary embolism, are aware of the complications they have experienced but are unaware of either what exactly those side effects indicate and what the difference is between the two popular birth control medications.
Both once-daily birth control pills are based on the hormone drospirenone, but Yaz has a higher dose of estrogen than Yasmin does. In addition, the Food and Drug Administration has approved Yaz for purposes other than preventing pregnancy, including treatment of mild to moderate acne and premenstrual dysphoric disorder, a more severe form of PMS. Yasmin is approved only for preventing pregnancy. Both come with the same set of side effects, however.

Yasmin DVT Put on Trial

Although trials of Yaz and Yasmin lawsuits are not set to begin until early next year, the drospirenone-based birth control pills are still a hot topic in the medical community. Many experts are arguing that, since many products are available that do the same job at a fraction of the risk, there is no value in keeping the controversial products on the market. Many patients have filed lawsuits against drugmaker Bayer, complaining of side effects they have suffered after taking the once-daily pill. The first bellwether trial involves a pulmonary embolism case. Pulmonary embolism is one of the most severe side effects of Yaz and Yasmin and occurs when a blood clot makes its way into a patient’s lung.

Despite Safety Concerns, Generic Forms of Yaz Birth Control Go Forward

Although Bayer has continued to maintain that there is no increased risk of blood clots fromYasmin and Yaz side effects, the FDA and European drug regulators forced the drug maker to update the blood clot warnings on Yaz and Yasmin labels last year. The FDA finally announced this week that they are evaluating the risk of blood clots from Yaz, Yasmin and Beyaz birth control, which some studies have shown to be 2 to 3 times greater than the risk associated with other birth control pills. The safety review was initiated based on two published studies that reported there is a greater risk of venous thromboembolism (VTE) among women taking Yaz, Yasmin or other drospirenone birth control pills.

Blood Clots and Hyperkalemia Linked to Yaz Birth Control

Growing concerns over the risk of Yaz blood clots from side effects of drospirenone, the active ingredient in Yaz and Yasmin birth control, has led Canadian health officials to launch an investigation, just one week after U.S. regulators launched a similar safety review of the popular pills. Notice of the safety review into a possible risk of blood clots with birth control pills containing drospirenone was released in the United States by the FDA on May 31, providing additional information for women taking the medications. The safety review was initiated based on two published studies that reported there is a greater risk of venous thromboembolism (VTE) among women taking Yaz, Yasmin or other drospirenone birth control pills. The risk has been reported to be up to 2 to 3 times greater than the risk associated with levonorgestrel birth control pills.